Personalis Announces NeXT Level Biomarkers Symposium
22.6.2021 16:01:00 EEST | Business Wire | Press release
Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, today announced its inaugural event, NeXT Level Biomarkers Symposium, which will showcase novel research into emerging biomarkers using the Personalis NeXT Platform™.
This event will detail the latest research from Personalis as well as a case study done in collaboration with the Parker Institute for Cancer Immunotherapy. Presentations from Personalis will focus on recently published research into HLA loss of heterozygosity, neoantigen prediction, as well as Personalis’ novel composite biomarker, the Neoantigen Presentation Score (NEOPS™). In addition, Dr. Theresa LaVallee will be presenting findings from the PRINCE trial based on data developed and analyzed in collaboration with Personalis.
The agenda for NeXT Level Biomarkers Symposium will cover:
- Biomarker Discovery with ImmunoID NeXT Platform®
- Exploring HLA LOH with the DASH (Deletion of Allele-Specific HLAs) Algorithm
- Neoantigen Binding Prediction and Biomarker Discovery with SHERPA™
- Composite Biomarkers and our Neoantigen Presentation Score (NEOPS™)
- Parker Institute Case Study: The PRINCE Trial
- NeXT Liquid Biopsy™ Overview and Review of AACR Data
- NeXT Dx™ and Companion Diagnostics (CDx) with Personalis
“We are excited to share our latest technology and product advances with our partners,” said Richard Chen, MD, Personalis CSO. “Given the complex biology underlying cancer progression and response to treatment, our mission at Personalis is to provide broader, more comprehensive molecular profiling and testing for each patient’s cancer, thereby giving biopharma, physicians, and patients the information they need for precision oncology now and with an eye to the future. These new technologies help further that mission.”
Further information, including registration information, on the NeXT Level Biomarkers Symposium can be found at this link.
About Personalis, Inc.
Personalis, Inc. is a leader in population sequencing and cancer genomics, with a focus on data, scale, efficiency, and quality. Personalis operates one of the largest sequencing operations globally and is currently the sole sequencing provider to the VA MVP. In oncology, Personalis is transforming the development of next-generation therapies by providing more comprehensive molecular data about each patient’s cancer and immune response. The Personalis® ImmunoID NeXT Platform® is designed to adapt to the complex and evolving understanding of cancer, providing its biopharmaceutical customers with information on all of the approximately 20,000 human genes, together with the immune system, from a single tissue sample. The Personalis Clinical Laboratory is GxP aligned as well as CLIA’88-certified and CAP-accredited. For more information, please visit www.personalis.com and follow Personalis on Twitter (@PersonalisInc).
Forward-Looking Statements
All statements in this press release that are not historical are “forward-looking statements” within the meaning of U.S. securities laws, including statements relating to attributes or advantages of the Personalis NeXT Platform, Personalis’ business opportunities, leadership, plans, vision or growth, or other future events. Such forward-looking statements involve risks and uncertainties, including those related to the COVID-19 pandemic, that could cause actual results to differ materially from any anticipated results or expectations expressed or implied by such statements. Factors that could materially affect actual results can be found in Personalis’ filings with the U.S. Securities and Exchange Commission, including Personalis’ most recent reports on Forms 8-K, 10-K and 10-Q, and include those listed under the caption “Risk Factors.” Personalis disclaims any obligation to update such forward-looking statements.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210622005462/en/
Contact information
Investor Relations Contact for Personalis:
Caroline Corner
investors@personalis.com
415-202-5678
Media Contact for Personalis:
Jennifer Havlek
pr@personalis.com
www.personalis.com
650-752-1300
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
AS Graanul Invest Appoints Energy Industry Veteran Lars Christian Bacher as Chief Executive Officer14.5.2026 15:45:00 EEST | Press release
ASGraanul Invest (“Graanul” or the “Company”), Europe’s largest producer of sustainable wood pellets used for electricity and heat production, today announces energy industry veteran Lars Christian Bacher will be joining the business as Chief Executive Officer, effective 18 May. Bacher will drive the Company’s growth across Europe as Graanul doubles down on its strategy to provide its customers with sustainable fuel to enable the production of renewable, dispatchable power and heat. Outgoing Chief Executive Nicholas Dottino will support Bacher with his transition to his new role as an advisor to Apollo on infrastructure and energy investments. Bacher joins Graanul having previously worked at Norwegian multinational energy company Equinor as a member of the Executive Committee for over eight years, including two years as Chief Financial Officer, where he had responsibility for managing financial operations and strategic planning. Prior to this, he was executive Vice President, Developme
Mobix Labs to Acquire U.S. Rare Earth and Critical Minerals Company Powering Defense and National Security14.5.2026 15:01:00 EEST | Press release
Mobix Labs, Inc. (Nasdaq: MOBX) today announced it has signed a non-binding Letter of Intent to acquire Special Project Delivery LLC ("SPD"), a strategic infrastructure platform building sovereign U.S. supply chains for rare earth elements, critical minerals, and energy storage. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260514342224/en/ U.S.A F-35 Lightning II The proposed acquisition would expand Mobix Labs — already a supplier to advanced U.S. and allied defense and aerospace systems — directly into one of the world's most strategically important industrial sectors. Key Facts at a Glance ~418 kilogramsof rare earth materials are estimated to be used in each F-35 Lightning II. ~4,500 kilogramsof rare earth materials are estimated to be used in each Virginia-class nuclear submarine. Tens of billions of dollars are already being deployed globally toward strategic critical-minerals infrastructure, with potential to reach
Mary Kay Launches Global Social Squad Program to Empower the Next Generation of Digital Beauty Leaders14.5.2026 15:00:00 EEST | Press release
Mary Kay Inc., a global leader in beauty and entrepreneurship, announces the launch of its Global Social Squad (GSS) Pilot Program – a groundbreaking initiative designed to empower Mary Kay Independent Beauty Consultants (IBCs) as dynamic digital brand advocates and next-generation social media storytellers. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260514978222/en/ The Global Social Squad ignites a diverse and talented group of 73 Mary Kay Independent Beauty Consultants with representation across 15 markets in four regions: North America, Asia Pacific, Latin America, and Europe. These digital leaders create engaging, high-quality content, participate in global campaign activations, and share practical social media strategies with their communities and other Independent Beauty Consultants, fuelling both brand relevance and business growth. (Image Courtesy: Mary Kay Inc.) Launching in select markets worldwide in 2026, th
Enterprise AI Hits the Wall: NTT DATA Research Reveals Growing Privacy and Sovereignty Barriers14.5.2026 15:00:00 EEST | Press release
NTT DATA, a global leader in AI, digital business and technology services, today released new research showing that enterprise AI is outgrowing the architecture and infrastructure beneath it as data privacy and sovereignty requirements tighten. The research finds a widening split between enterprises that are redesigning AI for control, locality and security, and organizations still layering AI into environments that were not built to support these requirements. For years, enterprise architecture moved data across systems, clouds, applications and borders with increasing speed and efficiency. AI is exposing the limits of that model. Sensitive data must be protected, workloads must run inside defined jurisdictions, and models must be governed under tighter controls. Data cannot always move with the speed and fluidity many AI systems expect, making jurisdiction a core architectural constraint. As a result, private and sovereign AI have become critical considerations. NTT DATA’s 2026 Globa
Vista Equity Partners Establishes Abu Dhabi Office14.5.2026 15:00:00 EEST | Press release
Vista Equity Partners (“Vista”), a global technology investor that specializes in enterprise software, today announced the opening of its new office in Abu Dhabi within ADGM, the city’s international financial center. VEPM Middle East Limited has received full authorization from ADGM’s Financial Services Regulatory Authority (FSRA), enabling the firm to advise on investments and arrange deals in investments across the region. The Abu Dhabi office reflects Vista’s expanded strategic presence in the Middle East and the region’s increasingly central role in global technology investment and innovation. Established in 2013, ADGM has emerged as one of the world’s leading financial centers, connecting global investors with regional opportunities. Vista joins a growing community of leading global investment firms that have established operations in ADGM, underscoring Abu Dhabi’s prominence as a destination for institutional capital. The expansion also reflects Abu Dhabi’s broader ambition to s
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom